Over the next few years, after being heavily promoted to physicians and the general public, Vioxx and Celebrex became widely used by millions of persons who had little risk of GI bleeding.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

Triggered by concerns over an increased risk of cardiovascular side effects, Merck announced on 30 September the withdrawal of rofecoxib (Vioxx), its leading drug for the management of rheumatoid ...

As you might guess, they only affect Cox-2 enzymes and not Cox-1. Two of them -- Bextra and Vioxx -- are no longer sold because of concerns about their side effects. The third, Celebrex ...

May 13, 2024 — Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil ...

May 8, 2024 — Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed ...

clopidogrel (Plavix), bivalirudin (Angiomax), and abciximab (ReoPro), and was the first physician to raise safety concerns about rofecoxib (Vioxx). He has published 1100 peer-reviewed articles and ...

The banned medicines include the diabetes drug Phenformin, which was linked to hundreds of deaths; the anti-inflammatory Vioxx, which caused serious heart damage; and the anti-diarrheal Lotronex.

These compounds, Celecoxib (known as Celebrex) and rofecoxib (known as Vioxx), have become some of the fastest selling drugs on the market. However, they too have their problems, as they promote ...

In this interview conducted at Pittcon 2024 in San Diego, we spoke to this year's Keynote Speaker Professor Omowunmi (Wunmi) ...

Do you live in one of the worst places for summer allergies? A-choo to you, Texas, Virginia, Kansas and California! You’re unlucky enough to be in one of the hotspots of this summer’s ...

International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome ...